India has rejected demand for data exclusivity in drug development in FTA talks: Commerce Secretary
Data exclusivity pertains to a clause in the draft agreement that puts a minimum six-year embargo on clinical trial data generated during the testing and development of a drug. File | Photo Credit: The Hindu India has rejected the demand for ‘data exclusivity’, as part of ongoing discussions with the European Free Trade Association (EFTA)…